Skip to main content

Musculoskeletal Tumors

  • Chapter
  • 2025 Accesses

Abstract

A 26-year-old female underwent 18F-FDG PET/CT after having diagnosed as Ewing sarcoma with a biopsy from a mass lesion located at left sacroiliac region.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Bibliography

  1. Bakri A, Shinagare AB, Krajewski KM, Howard SA, Jagannathan JP, Hornick JL, et al. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol. 2012;199:208–15. doi:10.2214/AJR.11.8039.

    Article  Google Scholar 

  2. Franzius C, Daldrup-Link HE, Sciuk J, Rummeny EJ, Bielack S, Jürgens H, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol. 2001;12:479–86.

    Article  CAS  PubMed  Google Scholar 

  3. Franzius C, Sciuk J, Daldrup-Link HE, Jürgens H, Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med. 2000;27:1305–11.

    Article  CAS  PubMed  Google Scholar 

  4. Halaç M, Zincirkeser S, Sönmezoğlu K, Sağer S, Dervişoğlu S, Uslu İ. Diagnosis of a giant sacral chordoma by FDG-PET. Turk J Nucl Med. 2006;15:78–80.

    Google Scholar 

  5. Kara PO, Gedik GK, Sari O, Kara T, Yilmaz F. FDG-PET/CT imaging in a patient with lymphangiosarcoma. Clin Nucl Med. 2010;35:428–9. doi:10.1097/RLU.0b013e3181db4d0f.

    Article  PubMed  Google Scholar 

  6. Lisle JW, Eary JF, O’Sullivan J, Conrad EU. Risk assessment based on FDG-PET imaging in patients with synovial sarcoma. Clin Orthop Relat Res. 2009;467:1605–11. doi:10.1007/s11999-008-0647-z.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Nanni C, Rubello D, Zamagni E, Castellucci P, Ambrosini V, Montini G, et al. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. In Vivo. 2008;22:513–7.

    PubMed  Google Scholar 

  8. Newman EN, Jones RL, Hawkins DS. An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma. Pediatr Blood Cancer. 2013;60:1113–7.

    Article  CAS  PubMed  Google Scholar 

  9. Ozguven S, Aras M, Inanir S. Mesenteric metastases of purely myxoid liposarcoma: an unusual behavior of primary tumor depicted on fludeoxyglucose positron emission tomography/computerized tomography. Indian J Nucl Med. 2015;30:82–3. doi:10.4103/0972-3919.147556.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Ozülker T, Ozülker F, Küçüköz Uzun A, Tatoğlu T, Ozpaçacı T. Evaluation of response to therapy in a patient with lung cancer: correlation of sclerotic bone lesions with F 18 FDG PET/CT and bone scintigraphy. Mol Imaging Radionucl Ther. 2011;20:29–33. doi:10.4274/MIRT.20.06.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Sabet A, Ahmadzadehfar H, Huertos Lopez FJ, Muckle M, Schmiedel A, Biersack HJ, et al. Detection of chordoma recurrence by F-18 FDG-PET/CT. Iran J Radiat Res. 2012;10:109–10.

    Google Scholar 

  12. Salaun PY, Gastinne T, Frampas E, Bodet-Milin C, Moreau P, Bodéré-Kraeber F. FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma. Haematologica. 2008;93:1269–71. doi:10.3324/haematol.12654.

    Article  PubMed  Google Scholar 

  13. Schirrmeister H, Buck AK, Bergmann L, Reske SN, Bommer M. Positron emission tomography (PET) for staging of solitary plasmacytoma. Cancer Biother Radiopharm. 2003;18:841–5.

    Article  PubMed  Google Scholar 

  14. Sharma P, Khangembam BC, Suman KC, Singh H, Rastogi S, Khan SA, et al. Diagnostic accuracy of 18 F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma. Eur J Nucl Med Mol Imaging. 2013;40:1036–43. doi:10.1007/s00259-013-2388-9.

    Article  CAS  PubMed  Google Scholar 

  15. von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Casper ES, et al. Soft tissue sarcoma, version 2.2014. J Natl Compr Canc Netw. 2014;12:473–83.

    Google Scholar 

  16. Yamamoto H, Sugimoto S, Miyoshi K, Yamamoto H, Soh J, Yamane M, et al. The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall. Kyobu Geka. 2014;67:4–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Özülker, T., Özülker, F. (2015). Musculoskeletal Tumors. In: Atlas of PET-CT Imaging in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-18994-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18994-9_16

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18993-2

  • Online ISBN: 978-3-319-18994-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics